Skip to content

Efficacy of probiotics in elderly patients with depression: A randomized placebo-controlled trial

Efficacy of adjunct probiotics in combination with standard of care as compared to standard of care alone in elderly patients with moderate unipolar depression: A randomized double-blind parallel-group placebo-controlled multi-center pilot trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061173
Enrollment
80
Registered
2024-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F321- Major depressive disorder, singleepisode, moderate

Interventions

Intervention1: probiotic: probiotic capsules containing more than 3 billion colony forming units of Lactobacillus helveticus and Bifidobacterium longum each once daily orally for 12 weeks Control Inte

Sponsors

Department of Health Research, Ministry of Health and Family Welfare, Government of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Elderly (=60 years) patients of both gender. 2. Patients with a present episode (=2 weeks) of moderate unipolar depression [Montgomery-Åsberg Depression Rating Scale (MADRS) score, 20–34]. 3. Patients who had not received any treatment for the present episode of depression.

Exclusion criteria

Exclusion criteria: 1. Patients who had taken a single dose of any antibiotic within the past 1 month. 2. Patients with psychosis or those with a severe suicidal tendency (according to Beck Scale for Suicidal Ideation). 3. Patients with a cognitive deficit [Montreal Cognitive Assessment (MoCA) score of 4. Patients with diagnosed irritable bowel syndrome or any absorption disorder.

Design outcomes

Primary

MeasureTime frame
•To compare the response rates at 12 weeks (proportion of patients achieving =50% reduction in the MADRS (Montgomery-Åsberg Depression Rating Scale) score from the corresponding scores at baseline) between the two groups.Timepoint: 12 weeks

Secondary

MeasureTime frame
• To compare the dosage of background antidepressants between the two groups at 12 weeks.Timepoint: 6, 12 & 24 weeks

Countries

India

Contacts

Public ContactDr Abhinaba Ghosh

ICMR

abhinaba.here@gmail.com9903465156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026